Roche mixes Actemra with Gilead's remdesivir in new COVID-19 trial Ruchika Sharma30 May 2020 12:45 PM ISTZurich: Roche plans to test if mixing its anti-inflammation drug Actemra with Gilead Sciences Inc's anti-viral treatment remdesivir works better...
Gilead holds talks with Health Ministry, DCGI officials to bring Remdesivir to India Ruchika Sharma23 May 2020 12:00 PM ISTThe medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA) to treat hospitalised...
Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir Ruchika Sharma15 May 2020 9:00 AM ISTHealth access groups say the pacts mean cheaper forms of the drug may not become available in nations seen as non-profitable to the five drugmakers
Hetero ties up with Gilead for Remdesivir Ruchika Sharma14 May 2020 12:16 PM ISTHetero will be supplying Remdesivir in 127 countries, including India, subject to regulatory approvals in respective countries
Jubilant Life Sciences enters into Licensing Agreement with Gilead for Remdesivir, potential therapy for Covid-19 Ruchika Sharma13 May 2020 9:15 AM ISTNoida: Jubilant Life Sciences Limited has announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive Licensing...
Gilead Sciences unveils plans of expanding global supply of Investigational Antiviral Remdesivir Ruchika Sharma8 May 2020 9:55 AM ISTFoster City: Bagging the USFDA nod for Emergency Use Authorization for remdesivir, maker Gilead sciences, recently announced its plans to increase its...
Health Ministry examining Remdesivir, minister cites Confusion over price and patent MD Bureau4 May 2020 11:03 PM ISTNew Delhi: Union Health Minister Harsh Vardhan on Monday said that there is a confusion over pricing and patent of experimental anti-viral drug...
Breakthrough: Gilead's Investigational Antiviral Remdesivir shows positive results in Stage 3 trial in Patients With Severe COVID-19 Ruchika Sharma30 April 2020 1:41 PM ISTNo new safety signals were identified with remdesivir across either treatment group
Natco settles patent suit with Gilead, others over Tamiflu savita thakur thakur15 Dec 2015 10:43 AM ISTNew Delhi: Natco Pharma and its partner Alvogen said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu, in a...
Hetero gets DCGI approval to market Hepatitis C drug savita thakur thakur9 Dec 2015 11:29 AM ISTNew Delhi: Drug maker Hetero has received approval from DCGI to market generic version of Gilead's Harvoni, a drug used in the treatment of Hepatitis...
Gilead Sciences keen to set up manufacturing unit in Hyderabad savita thakur thakur7 Dec 2015 10:36 AM ISTHyderabad: US-based Gilead Sciences, a research-based company, has evinced interest in setting up a manufacturing unit in the proposed 'Pharma City'...
$1350 for a hepatitis C Pill- Really? Meghna A Singhania12 July 2015 11:20 AM ISTCalifornia-based Gilead Sciences, had made the news earlier with its hepatitis C drug, n only  because of its efficacy in treating hepatitis C but...
